ACADIA Pharmaceuticals Inc. v. Aurobindo Pharma Limited et al
ACADIA Pharmaceuticals Inc. |
Aurobindo Pharma USA, Inc. and Aurobindo Pharma Limited |
1:2020cv00985 |
July 24, 2020 |
US District Court for the District of Delaware |
Richard G Andrews |
Patent - Abbreviated New Drug Application(ANDA) |
35 U.S.C. § 271 |
None |
Docket Report
This docket was last retrieved on December 13, 2023. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 13 MOTION for Pro Hac Vice Appearance of Attorney George J. Barry III and Attorney Timothy H. Kratz - filed by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc.. (Dorsney, Kenneth) |
SO ORDERED, re #13 MOTION for Pro Hac Vice Appearance of Attorney George J. Barry III and Attorney Timothy H. Kratz, filed by Aurobindo Pharma USA, Inc., Aurobindo Pharma Limited. Signed by Judge Richard G. Andrews on 9/15/2020. (nms) |
Filing 12 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,659,285 ;7,923,564 ;8,618,130 ;8,921,393 ;9,566,271 ;10,028,944 . (Dorsney, Kenneth) |
Filing 11 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Aurobindo Pharma, Ltd. for Aurobindo Pharma USA, Inc. filed by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc.. (Dorsney, Kenneth) |
Filing 10 ANSWER to #1 Complaint, , COUNTERCLAIM against ACADIA Pharmaceuticals Inc. by Aurobindo Pharma USA, Inc., Aurobindo Pharma Limited. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F)(Dorsney, Kenneth) |
SO ORDERED, re #9 STIPULATION TO EXTEND TIME to answer, move or otherwise respond to the Complaint to September 1, 2020 (*Reset Answer Deadlines: Aurobindo Pharma Limited answer due 9/1/2020; Aurobindo Pharma USA, Inc. answer due 9/1/2020). Signed by Judge Richard G. Andrews on 8/17/2020. (nms) |
Filing 9 STIPULATION TO EXTEND TIME for Defendants Aurobindo Pharma Limited and Aurobindo Pharma USA, Inc. to answer, move or otherwise respond to the Complaint to September 1, 2020 - filed by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc.. (Dorsney, Kenneth) |
Filing 8 AFFIDAVIT of Service for Complaint served on Timothy H. Kratz, Esq. on July 28, 2020, filed by ACADIA Pharmaceuticals Inc.. (Attachments: #1 Exhibit A & B)(Taylor, James) |
Pro Hac Vice Attorneys Chad J. Peterman, Bruce M. Wexler, Scott F. Peachman for ACADIA Pharmaceuticals Inc. and ACADIA Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:20-cv-00986-RGA, 1:20-cv-00985-RGA(kmd) |
CORRECTING ENTRY: Added Related Cases per Letter Dated 7/31/20. Associated Cases: 1:20-cv-00986-RGA, 1:20-cv-00985-RGA, 1:20-cv-01021-UNA, 1:20-cv-01022-UNA, 1:20-cv-01029-UNA(rwc) |
Filing 7 MOTION for Pro Hac Vice Appearance of Attorney Chad J. Peterman, Bruce M. Wexler, Scott F. Peachman - filed by ACADIA Pharmaceuticals Inc.. (Taylor, James) |
SO ORDERED, re #7 MOTION for Pro Hac Vice Appearance of Attorney Chad J. Peterman, Bruce M. Wexler, Scott F. Peachman, filed by ACADIA Pharmaceuticals Inc.. Signed by Judge Richard G. Andrews on 7/29/2020. (nms) |
Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. Associated Cases: 1:20-cv-00985-RGA, 1:20-cv-00986-RGA (rjb) |
Filing 6 SUMMONS Returned Executed by ACADIA Pharmaceuticals Inc.. Aurobindo Pharma USA, Inc. served on 7/28/2020, answer due 8/18/2020. (Taylor, James) |
Filing 5 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by ACADIA Pharmaceuticals Inc.. (Taylor, James) |
No Summons Issued. (mal) |
Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,601,740 ;7,732,615 ;10,449,185 ;10,646,480. (mal) |
Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: June 18, 2020. Date of Expiration of Patent: see attached. Thirty Month Stay Deadline: see attached. (mal) |
Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mal) |
Filing 1 COMPLAINT filed against Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number ADEDC-3084868.) - filed by ACADIA Pharmaceuticals Inc.. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Civil Cover Sheet)(mal) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.